Literature DB >> 29145581

Prospective Epidemiological Research Studies in Iran (the PERSIAN Cohort Study): Rationale, Objectives, and Design.

Hossein Poustchi1, Sareh Eghtesad1, Farin Kamangar2,3, Arash Etemadi4, Abbas-Ali Keshtkar5, Azita Hekmatdoost6, Zahra Mohammadi1, Zahra Mahmoudi1, Amaneh Shayanrad1, Farzin Roozafzai1, Mahdi Sheikh1, Alireza Jalaeikhoo1, Mohammad Hossein Somi7, Fariborz Mansour-Ghanaei8, Farid Najafi9, Ehsan Bahramali10, Amirhoushang Mehrparvar11, Alireza Ansari-Moghaddam12, Ahmad Ali Enayati13, Ali Esmaeili Nadimi14, Abbas Rezaianzadeh15, Nader Saki16, Fatemeh Alipour17, Roya Kelishadi18, Afarin Rahimi-Movaghar19, Nayyereh Aminisani20, Paolo Boffetta21, Reza Malekzadeh3.   

Abstract

Noncommunicable diseases (NCDs) account for 76% of deaths in Iran, and this number is on the rise, in parallel with global rates. Many risk factors associated with NCDs are preventable; however, it is first necessary to conduct observational studies to identify relevant risk factors and the most appropriate approach to controlling them. Iran is a multiethnic country; therefore, in 2014 the Ministry of Health and Medical Education launched a nationwide cohort study-Prospective Epidemiological Research Studies in Iran (PERSIAN)-in order to identify the most prevalent NCDs among Iran's ethnic groups and to investigate effective methods of prevention. The PERSIAN study consists of 4 population-based cohorts; the adult component (the PERSIAN Cohort Study), described in this article, is a prospective cohort study including 180,000 persons aged 35-70 years from 18 distinct areas of Iran. Upon joining the cohort, participants respond to interviewer-administered questionnaires. Blood, urine, hair, and nail samples are collected and stored. To ensure consistency, centrally purchased equipment is sent to all sites, and the same team trains all personnel. Routine visits and quality assurance/control measures are taken to ensure protocol adherence. Participants are followed for 15 years postenrollment. The PERSIAN study is currently in the enrollment phase; cohort profiles will soon emerge.

Entities:  

Mesh:

Year:  2018        PMID: 29145581      PMCID: PMC6279089          DOI: 10.1093/aje/kwx314

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  18 in total

1.  The nurses' health study.

Authors:  C F Belanger; C H Hennekens; B Rosner; F E Speizer
Journal:  Am J Nurs       Date:  1978-06       Impact factor: 2.220

Review 2.  Statistical methods in cancer research. Volume II--The design and analysis of cohort studies.

Authors:  N E Breslow; N E Day
Journal:  IARC Sci Publ       Date:  1987

3.  Hazards of cigarettes, smokeless tobacco and waterpipe in a Middle Eastern Population: a Cohort Study of 50 000 individuals from Iran.

Authors:  Arash Etemadi; Hooman Khademi; Farin Kamangar; Neal D Freedman; Christian C Abnet; Paul Brennan; Reza Malekzadeh
Journal:  Tob Control       Date:  2016-11-21       Impact factor: 7.552

4.  A pilot double-blind randomised placebo-controlled trial of the effects of fixed-dose combination therapy ('polypill') on cardiovascular risk factors.

Authors:  F Malekzadeh; T Marshall; A Pourshams; M Gharravi; A Aslani; A Nateghi; M Rastegarpanah; M Khoshnia; S Semnani; R Salahi; G N Thomas; B Larijani; K K Cheng; R Malekzadeh
Journal:  Int J Clin Pract       Date:  2010-08       Impact factor: 2.503

5.  National and Subnational Patterns of Cause of Death in Iran 1990-2015: Applied Methods.

Authors:  Ali Sheidaei; Kimiya Gohari; Amir Kasaeian; Nazila Rezaei; Anita Mansouri; Ardeshir Khosravi; Mahboubeh Parsaeian; Younes Mohammadi; Parinaz Mehdipour; Shadi Rahimzadeh; Farshad Sharifi; Mehdi Varmaghani; Maryam Chegini; Shohreh Naderimagham; Hamid Reza Jamshidi; Farshad Farzadfar
Journal:  Arch Iran Med       Date:  2017-01       Impact factor: 1.354

6.  Cancer incidence and mortality in Iran.

Authors:  S M Mousavi; M M Gouya; R Ramazani; M Davanlou; N Hajsadeghi; Z Seddighi
Journal:  Ann Oncol       Date:  2008-12-10       Impact factor: 32.976

7.  Opium use and mortality in Golestan Cohort Study: prospective cohort study of 50,000 adults in Iran.

Authors:  Hooman Khademi; Reza Malekzadeh; Akram Pourshams; Elham Jafari; Rasool Salahi; Shahryar Semnani; Behrooz Abaie; Farhad Islami; Siavosh Nasseri-Moghaddam; Arash Etemadi; Graham Byrnes; Christian C Abnet; Sanford M Dawsey; Nicholas E Day; Paul D Pharoah; Paolo Boffetta; Paul Brennan; Farin Kamangar
Journal:  BMJ       Date:  2012-04-17

8.  Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations.

Authors:  Jimmy Z Liu; Suzanne van Sommeren; Hailiang Huang; Siew C Ng; Rudi Alberts; Atsushi Takahashi; Stephan Ripke; James C Lee; Luke Jostins; Tejas Shah; Shifteh Abedian; Jae Hee Cheon; Judy Cho; Naser E Dayani; Lude Franke; Yuta Fuyuno; Ailsa Hart; Ramesh C Juyal; Garima Juyal; Won Ho Kim; Andrew P Morris; Hossein Poustchi; William G Newman; Vandana Midha; Timothy R Orchard; Homayon Vahedi; Ajit Sood; Joseph Y Sung; Reza Malekzadeh; Harm-Jan Westra; Keiko Yamazaki; Suk-Kyun Yang; Jeffrey C Barrett; Behrooz Z Alizadeh; Miles Parkes; Thelma Bk; Mark J Daly; Michiaki Kubo; Carl A Anderson; Rinse K Weersma
Journal:  Nat Genet       Date:  2015-07-20       Impact factor: 41.307

9.  Mortality and cancer in relation to ABO blood group phenotypes in the Golestan Cohort Study.

Authors:  Arash Etemadi; Farin Kamangar; Farhad Islami; Hossein Poustchi; Akram Pourshams; Paul Brennan; Paolo Boffetta; Reza Malekzadeh; Sanford M Dawsey; Christian C Abnet; Ashkan Emadi
Journal:  BMC Med       Date:  2015-01-15       Impact factor: 8.775

10.  Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case-control study.

Authors:  Farhad Islami; Akram Pourshams; Dariush Nasrollahzadeh; Farin Kamangar; Saman Fahimi; Ramin Shakeri; Behnoush Abedi-Ardekani; Shahin Merat; Homayoon Vahedi; Shahryar Semnani; Christian C Abnet; Paul Brennan; Henrik Møller; Farrokh Saidi; Sanford M Dawsey; Reza Malekzadeh; Paolo Boffetta
Journal:  BMJ       Date:  2009-03-26
View more
  126 in total

1.  Lifetime prevalence of recurrent aphthous stomatitis and its related factors in Northern Iranian population: The PERSIAN Guilan Cohort Study.

Authors:  Abbas Darjani; Farahnaz Joukar; Mohammareza Naghipour; Mehrnaz Asgharnezhad; Fariborz Mansour-Ghanaei
Journal:  Clin Oral Investig       Date:  2020-10-08       Impact factor: 3.573

2.  The profile of Rafsanjan Cohort Study.

Authors:  Hamid Hakimi; Jafar Ahmadi; Alireza Vakilian; Ahmad Jamalizadeh; Zahra Kamyab; Mahya Mehran; Reza Malekzadeh; Hossein Poustchi; Sareh Eghtesad; Farimah Sardari; Mohammadreza Soleimani; Morteza Khademalhosseini; Mohammadreza Abolghasemi; Movahedeh Mohammadi; Tabandeh Sadeghi; Fatemeh Ayoobi; Mitra Abbasi; Maryam Mohamadi; Zahra Jalali; Ali Shamsizadeh; Ali Esmaeili-Nadimi
Journal:  Eur J Epidemiol       Date:  2020-07-28       Impact factor: 8.082

3.  Comparison of anthropometric indices as predictors of the risk factors for cardiovascular disease in Iran: The PERSIAN Guilan Cohort Study.

Authors:  Marjan Mahdavi-Roshan; Arezoo Rezazadeh; Farahnaz Joukar; Mohammadreza Naghipour; Soheil Hassanipour; Fariborz Mansour-Ghanaei
Journal:  Anatol J Cardiol       Date:  2021-02       Impact factor: 1.596

4.  The prevalence and predictors of pre-hypertension and hypertension in Kherameh cohort study: a population based study on 10,663 persons in south of Iran.

Authors:  Abbas Rezaianzadeh; Fatemeh Jafari; Seyed Ebrahim Sadeghi; Salar Rahimikazerooni
Journal:  J Hum Hypertens       Date:  2020-03-17       Impact factor: 3.012

5.  Seroepidemiology and risk factors of hepatitis C virus infection in East Azerbaijan, Iran: a population-based Azar Cohort study.

Authors:  Ali Asghar Pouri; Morteza Ghojazadeh; Behrouz Pourasghari; Babak Baiaz; Fatemeh Soghra Hamzavi; Mohammad Hossein Somi
Journal:  Caspian J Intern Med       Date:  2019

6.  Prevalence of metabolic syndrome using international diabetes federation, National Cholesterol Education Panel- Adult Treatment Panel III and Iranian criteria: results of Tabari cohort study.

Authors:  Adeleh Bahar; Zahra Kashi; Motahareh Kheradmand; Akbar Hedayatizadeh-Omran; Mahdi Moradinazar; Fatemeh Ramezani; Mahdi Afshari; Mahmood Moosazadeh
Journal:  J Diabetes Metab Disord       Date:  2020-01-17

7.  Predicting Metabolic Syndrome by Visceral Adiposity Index, Body Roundness Index and a Body Shape Index in Adults: A Cross-Sectional Study from the Iranian RaNCD Cohort Data.

Authors:  Kamran Baveicy; Shayan Mostafaei; Mitra Darbandi; Behrooz Hamzeh; Farid Najafi; Yahya Pasdar
Journal:  Diabetes Metab Syndr Obes       Date:  2020-03-24       Impact factor: 3.168

8.  Association of maternal urinary concentration of parabens and neonatal anthropometric indices.

Authors:  Hamidreza Pourzamani; Roya Kelishadi; Saeid Fadaei; Karim Ebrahimpour; Awat Feizi; Seyede Shahrbanoo Daniali
Journal:  J Environ Health Sci Eng       Date:  2020-06-12

9.  Agreement between laboratory-based and non-laboratory-based Framingham risk score in Southern Iran.

Authors:  Fatemeh Rezaei; Mozhgan Seif; Abdullah Gandomkar; Mohammad Reza Fattahi; Jafar Hasanzadeh
Journal:  Sci Rep       Date:  2021-05-24       Impact factor: 4.379

10.  Socioeconomic inequality in noncommunicable diseases: Results from a baseline Persian cohort study.

Authors:  Mehdi Sharafi; Ehsan Bahramali; Mojtaba Farjam; Shahab Rezaeian; Sima Afrashteh; Zahra Amiri
Journal:  Med J Islam Repub Iran       Date:  2021-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.